Clinical trial
Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
NCT07095517
Study timeline
Study start (actual)2026-02-24Date precision: day
Registry last updated2026-02-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Colorectal Cancer Preventionunresolved
Colorectal Adenomaunresolved
Interventions
TirzepatideDRUG · verified · RxNorm: tirzepatide
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
National Cancer Institute (NCI)collaborator
Cancer Research UKcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07095517 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.